Global measles elimination

Measles remains a leading vaccine-preventable cause of child mortality worldwide, particularly in sub-Saharan Africa where almost half of the estimated 454,000 measles deaths in 2004 occurred. However, great progress in measles control has been made in resource-poor countries through accelerated measles-control efforts. The global elimination of measles has been debated since measles vaccines were first licensed in the 1960's, and this debate is likely to be renewed if polio virus is eradicated. This review discusses the pathogenesis of measles and the likelihood of the worldwide elimination of this disease.

• Publication year

  2006

• Venue

  Nature Reviews Microbiology

• Publication date

  2006-11-06

• Fields of study

  Biology, Medicine, Environmental Science

• Identifiers
  DOI 10.1038/nrmicro1550PMID 17088933PMCID 7097605
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• An epidemic of measles in southern Greenland 1951; measles in virgin soil. IV. The significance of specific prophylaxis.

  2009cited by this paper
• Polio eradication and measles immunisation in Nigeria.

  2006cited by this paper
• Genetic variability of measles virus in acute and persistent infections.

  2006cited by this paper
• Progress in reducing global measles deaths, 1999-2004.

  2006cited by this paper
• Polio--new challenges in 2006.

  2006cited by this paper
• Inaugural Article: Modulation of disease, T cell responses, and measles virus clearance in monkeys vaccinated with H-encoding alphavirus replicon particles

  2005cited by this paper
• Progress in reducing measles mortality--worldwide, 1999-2003.

  2005cited by this paper
• New Measles Genotype, Uganda

  2005cited by this paper
• Public-health impact of accelerated measles control in the WHO African Region 2000-03.

  2005cited by this paper
• A novel intranasal Protollin-based measles vaccine induces mucosal and systemic neutralizing antibody responses and cell-mediated immunity in mice.

  2005cited by this paper
• Progress in reducing global measles deaths: 1999-2003.

  2005cited by this paper
• Evaluating the impact of the HIV pandemic on measles control and elimination.

  2005cited by this paper
• The development of a plant-based vaccine for measles.

  2005cited by this paper
• Induction of cellular and humoral immunity after aerosol or subcutaneous administration of Edmonston-Zagreb measles vaccine as a primary dose to 12-month-old children.

  2004cited by this paper
• Cost-effectiveness of three different vaccination strategies against measles in Zambian children.

  2004cited by this paper
• Can measles be eradicated globally

  2004cited by this paper
• Can measles be eradicated globally?

  2004cited by this paper
• Protection against challenge with measles virus (MV) in infant macaques by an MV DNA vaccine administered in the presence of neutralizing antibody.

  2004cited by this paper
• Following in the footsteps of smallpox: can we achieve the global eradication of measles?

  2004cited by this paper
• Genetic analysis of measles viruses isolated in the united states between 1989 and 2001: absence of an endemic genotype since 1994.

  2004cited by this paper
• Communicable diseases in complex emergencies: impact and challenges.

  2004cited by this paper
• Circulating vaccine-derived polioviruses: current state of knowledge.

  2004cited by this paper
• MMR vaccine and autism: an update of the scientific evidence

  2004cited by this paper
• Economic analysis of the 1996-1997 mass measles immunization campaigns in South Africa.

  2004cited by this paper
• Variation in vaccine response in normal populations.

  2004cited by this paper
• Measles Vaccines and the Potential for Worldwide Eradication of Measles

  2004cited by this paper
• Communicating science to the public: MMR vaccine and autism.

  2003cited by this paper
• The challenges and strategies for laboratory diagnosis of measles in an international setting.

  2003cited by this paper
• Measles : Not just another viral exanthem

  2003cited by this paper
• Update on the global distribution of genotypes of wild type measles viruses.

  2003cited by this paper
• CD46- and CD150-independent endothelial cell infection with wild-type measles viruses.

  2003cited by this paper
• Role of CD8+ Lymphocytes in Control and Clearance of Measles Virus Infection of Rhesus Monkeys

  2003cited by this paper
• DNA vaccination of infants in the presence of maternal antibody: a measles model in the primate.

  2003cited by this paper
• Measles Outbreaks in a Population with Declining Vaccine Uptake

  2003cited by this paper
• Update of the nomenclature for describing the genetic characteristics of wild-type measles viruses: new genotypes and reference strains.

  2003cited by this paper
• Attenuated Salmonella enterica Serovar Typhi and Shigella flexneri 2a Strains Mucosally Deliver DNA Vaccines Encoding Measles Virus Hemagglutinin, Inducing Specific Immune Responses and Protection in Cotton Rats

  2003cited by this paper
• Frequency of Measles Virus-Specific CD4+ and CD8+ T Cells in Subjects Seronegative or Highly Seropositive for Measles Vaccine

  2003cited by this paper
• First 5 years of measles elimination in southern Africa: 1996-2000.

  2002cited by this paper
• A Population-Based Study of Measles, Mumps, and Rubella Vaccination and Autism

  2002cited by this paper
• Measles virus and immunomodulation: molecular bases and perspectives

  2002cited by this paper
• A population-based study of measles, mumps, and rubella vaccination and autism.

  2002cited by this paper
• Aerosolized measles and measles-rubella vaccines induce better measles antibody booster responses than injected vaccines: randomized trials in Mexican schoolchildren.

  2002cited by this paper
• Differential regulation of interleukin (IL)-4, IL-5, and IL-10 during measles in Zambian children.

  2002cited by this paper
• Efficiency of Measles Virus Entry and Dissemination through Different Receptors

  2002cited by this paper
• Prolonged measles virus shedding in human immunodeficiency virus-infected children, detected by reverse transcriptase-polymerase chain reaction.

  2001cited by this paper
• A Chimeric Human-Bovine Parainfluenza Virus Type 3 Expressing Measles Virus Hemagglutinin Is Attenuated for Replication but Is Still Immunogenic in Rhesus Monkeys

  2001cited by this paper
• Natural measles causes prolonged suppression of interleukin-12 production.

  2001cited by this paper
• V and C proteins of measles virus function as virulence factors in vivo.

  2000cited by this paper
• Consequences of Fas-Mediated Human Dendritic Cell Apoptosis Induced by Measles Virus

  2000cited by this paper
• Measles eradication: is it in our future?

  2000cited by this paper
• Individual and community risks of measles and pertussis associated with personal exemptions to immunization.

  2000cited by this paper
• Response to different measles vaccine strains given by aerosol and subcutaneous routes to schoolchildren: a randomised trial.

  2000cited by this paper
• Eradication of poliomyelitis in countries affected by conflict.

  2000cited by this paper
• Strategies for reducing global measles mortality.

  2000cited by this paper
• Successful DNA immunization against measles: Neutralizing antibody against either the hemagglutinin or fusion glycoprotein protects rhesus macaques without evidence of atypical measles

  2000cited by this paper
• The Immunological Basis for Immunization Series

  2000cited by this paper
• Isolation of measles virus from a naturally-immune, asymptomatically re-infected individual.

  1999cited by this paper
• Measles elimination: progress and challenges.

  1999cited by this paper
• Modeling the impact of subclinical measles transmission in vaccinated populations with waning immunity.

  1999cited by this paper
• Implications of the human immunodeficiency virus epidemic for control and eradication of measles.

  1999cited by this paper
• Effect of subclinical infection on maintaining immunity against measles in vaccinated children in West Africa.

  1999cited by this paper
• Recombinant Measles Viruses with Mutations in the C, V, or F Gene Have Altered Growth Phenotypes In Vivo

  1998cited by this paper
• Vaccine-Associated Measles Pneumonitis in an Adult with AIDS

  1998cited by this paper
• Deficiency of the humoral immune response to measles vaccine in infants immunized at age 6 months.

  1998cited by this paper
• Ileal-lymphoid-nodular hyperplasia, non-specific colitis, and pervasive developmental disorder in children.

  1998cited by this paper
• Ileal-lymphoid-nodular hyperplasia, non-specific colitis, and pervasive developmental disorder in children.

  1998cited by this paper
• The progress of the Polio Eradication Initiative: what prospects for eradicating measles?

  1998cited by this paper
• The assembly of the measles virus nucleoprotein into nucleocapsid-like particles is modulated by the phosphoprotein.

  1997cited by this paper
• Measles eradication: recommendations from a meeting cosponsored by the World Health Organization, the Pan American Health Organization, and CDC.

  1997cited by this paper
• Secondary failure rates of measles vaccines: a metaanalysis of published studies.

  1996cited by this paper
• Mechanism of Suppression of Cell-Mediated Immunity by Measles Virus

  1996cited by this paper
• The effect of dose and strain of live attenuated measles vaccines on serological responses in young infants.

  1995cited by this paper
• Measles virus glycoproteins: studies on the structure and interaction of the haemagglutinin and fusion proteins.

  1993cited by this paper
• Differential CD4 T cell activation in measles.

  1993cited by this paper
• Measles-associated diarrhea in hospitalized children in Lima, Peru: pathogenic agents and impact on growth.

  1991cited by this paper
• Plagues and peoples, William H. McNeill.

  1988cited by this paper
• Prospective study of the magnitude and duration of changes in tuberculin reactivity during uncomplicated and complicated measles

  1987cited by this paper
• Factors associated with fatal cases of measles. A retrospective autopsy study.

  1985cited by this paper
• Changes in plasma IgE levels during complicated and uncomplicated measles virus infections.

  1985cited by this paper
• Cellular immune responses during complicated and uncomplicated measles virus infections of man.

  1984cited by this paper
• Alterations in immune responsiveness in acute measles and chronic post-measles chest disease.

  1978cited by this paper
• Plagues and Peoples

  1977cited by this paper
• Persistent measles infection in malnourished children.

  1977cited by this paper
• Epidemiologic basis for eradication of measles in 1967.

  1967cited by this paper
• Measles endemicity in insular populations: critical community size and its evolutionary implication.

  1966cited by this paper
• Studies on an attenuated measles-virus vaccine. I. Development and preparations of the vaccine: technics for assay of effects of vaccination.

  1960cited by this paper
• Inapparent measles after gamma globulin administration.

  1960cited by this paper
• Disturbances in gamma globulin synthesis as experiments of nature.

  1956cited by this paper
• Propagation in Tissue Cultures of Cytopathogenic Agents from Patients with Measles.†

  1954cited by this paper
• An epidemic of measles in southern Greenland, 1951; measles in virgin soil. II. The epidemic proper.

  1953cited by this paper
• ON MEASLES

  1908cited by this paper

• Assessing measles immunity in individuals of childbearing age in Toronto, Ontario, Canada.

  2026cites this paper
• Risk Analysis of Measles Outbreaks in Bulgaria and Romania for the Period 2000 to 2023: A Comparative Study

  2025influential citation
• Discovery of potent measles virus fusion inhibitor peptides via structure-guided derivatization

  2025cites this paper
• Overview of laboratory-confirmed measles cases in Ivory Coast between 2003 and 2022

  2025cites this paper
• Epidemiology, clinical overview, and potential risk of a new pandemic of measles virus

  2025cites this paper
• Measles Immunity Gaps: Distinct Serological Profiles from the United States and India.

  2025cites this paper
• Evaluation of measles elimination strategies in Dongola, Sudan: a surveillance and immunization converge analysis, 2018–2021

  2025cites this paper
• Analysis of Google News Coverage During the 2025 U.S. Measles Outbreak.

  2025cites this paper
• Tracking wild-type measles virus in wastewater using multiplex RT-dPCR, A novel tool for measles surveillance.

  2025cites this paper
• Global, regional, and national trends of measles burden and its vaccination coverage among children under five years old: an updated systematic analysis from the Global Burden of Disease study 2021.

  2025cites this paper
• Measles seroprevalence among health care professionals during a period of increased transmission: A pilot study in Southern Italy

  2025cites this paper
• Targeted therapeutic strategies for Nectin-4 in breast cancer: Recent advances and future prospects

  2024cites this paper
• Effects of behavioral observability and social proof on the coupled epidemic-awareness dynamics in multiplex networks

  2024cites this paper
• Measles and Rubella Diagnostic and Classification Challenges in Near- and Post-Elimination Countries

  2024cites this paper
• Hospital-acquired infections and unvaccinated children due to chronic diseases: an investigation of the 2017–2019 measles outbreak in the northern region of Vietnam

  2024cites this paper
• Two centuries of vaccination: historical and conceptual approach and future perspectives

  2024cites this paper
• Helical peptides with disordered regions for measles viruses provide new generalized insights into fusion inhibitors

  2024cites this paper
• A Comprehensive Review on Rubella Virus

  2024cites this paper
• Information-epidemic co-evolution propagation under policy intervention in multiplex networks

  2023cites this paper
• Epidemiological and Clinical Characteristics of Measles in Jinan, Shandong Province, China, from 1991 to 2022

  2023cites this paper
• Analysis of the different interventions scenario for programmatic measles control in Bangladesh: A modelling study

  2023cites this paper
• A Lesson from a Measles Outbreak among Healthcare Workers in a Single Hospital in South Korea: The Importance of Knowing the Prevalence of Susceptibility

  2023cites this paper
• Measles-Associated Pneumonia in Children: A Report from Pediatrics Department of Gabriel Toure University Teaching Hospital

  2023cites this paper
• Polish Legislation and Health Policy against the Background of Achievement of the Assumptions and Objectives of the Measles Eradication Programme in the European Region

  2023cites this paper
• Epidemiology of measles in Angola: Results from routine surveillance from 2015 to 2021

  2023cites this paper
• Measles second dose vaccine utilization and associated factors among children aged 24–35 months in Sub-Saharan Africa, a multi-level analysis from recent DHS surveys

  2022cites this paper
• Advances in RNA Viral Vector Technology to Reprogram Somatic Cells: The Paramyxovirus Wave

  2022cites this paper
• Breakthrough Infections: A Challenge towards Measles Elimination?

  2022influential citation
• Immunogenicity after outbreak response immunization activities among young healthcare workers with secondary vaccine failure during the measles epidemic in Korea, 2019

  2022cites this paper
• Current Status of Immunology Education in U.S. Medical Schools.

  2022cites this paper
• [Reactivation of latent viruses in Neurology].

  2022cites this paper
• Molecular Epidemiological Study of Measles Cases in Gyeonggi Province

  2022cites this paper
• Trends, barriers and enablers to measles immunisation coverage in Saskatchewan, Canada: A mixed methods study

  2022cites this paper
• Hollow Pt Nanocage@Mesoporous SiO2 Nanoreactors as a Nanozyme for Colorimetric Immunoassays of Viral Diagnosis

  2021cites this paper
• A REVIEW OF MEASLES VIRUS

  2021influential citation
• Inhibition of Viral Membrane Fusion by Peptides and Approaches to Peptide Design

  2021cites this paper
• Nanodelivery of STING agonists against cancer and infectious diseases.

  2021cites this paper
• Vaccination Against COVID-19 as a Christian Duty? A Risk-Analytic Approach

  2021influential citation
• Environmental Risk Assessment of Recombinant Viral Vector Vaccines against SARS-Cov-2

  2021cites this paper
• The next phase in Aotearoa New Zealand's COVID-19 response: a tight suppression strategy may be the best option.

  2021cites this paper
• Three-year prevalence of measles antibody seropositivity at a tertiary care hospital in Turkey

  2021cites this paper
• Electroencephalography Patterns of Subacute Sclerosing Panencephalitis

  2021cites this paper
• Mechanisms and Consequences of Newcastle Disease Virus W Protein Subcellular Localization in the Nucleus or Mitochondria

  2021cites this paper
• Brief Introduction of Measles Virus and Its Therapeutic Strategies

  2021cites this paper
• Adenosine-to-inosine RNA editing in neurological development and disease

  2021cites this paper
• Fine-scale spatial clustering of measles nonvaccination that increases outbreak potential is obscured by aggregated reporting data

  2020influential citation
• COVID-19 coronavirus: pathogenesis, clinical features, diagnostics, epidemiology, prevention and control

  2020cites this paper
• The Importance of MMR Immunization in the United States

  2020cites this paper
• Human Acute and Chronic Viruses: Host-Pathogen Interactions and Therapeutics

  2020cites this paper
• Measles Resurgence and Drug Development.

  2020cites this paper
• Are the Objectives Proposed by the WHO for Routine Measles Vaccination Coverage and Population Measles Immunity Sufficient to Achieve Measles Elimination from Europe?

  2020cites this paper
• Evaluating the effectiveness of national measles elimination action in mainland China during 2004-2016: A multi-site interrupted time-series study.

  2020cites this paper
• Estimating the nationwide transmission risk of measles in US schools and impacts of vaccination and supplemental infection control strategies

  2020cites this paper
• Peptide Inhibitors of Viral Membrane Fusion

  2020cites this paper
• Vaccine hesitancy

  2020cites this paper
• Virus Infections of the Central Nervous System

  2020cites this paper
• The uneasy coexistence of predators and pathogens

  2020cites this paper
• Containing a measles outbreak in Minnesota, 2017: methods and challenges

  2020cites this paper
• Polymeric nanoparticle vaccines to combat emerging and pandemic threats

  2020cites this paper
• Impact on Routine Immunization Services During the Lockdown Period in India: Implications and Future Recommendations

  2020cites this paper
• Measles Seroprevalence in Yozgat City Hospital Employees

  2020cites this paper
• Antiviral Drug Targets of Single-Stranded RNA Viruses Causing Chronic Human Diseases.

  2020cites this paper
• Transmission Network of Measles During the Yamagata Outbreak in Japan, 2017

  2020cites this paper
• Investigation of a measles transmission with vaccination: a case study in Jakarta, Indonesia.

  2020cites this paper
• Chaos in disease outbreaks among prey

  2020cites this paper
• Crosstalk between oncolytic viruses and autophagy in cancer therapy.

  2020cites this paper
• Immunodomination of Serotype-Specific CD4+ T-Cell Epitopes Contributed to the Biased Immune Responses Induced by a Tetravalent Measles-Vectored Dengue Vaccine

  2020cites this paper
• Type 1 Interferon Responses Underlie Tumor-Selective Replication of Oncolytic Measles Virus.

  2020cites this paper
• Association between access to a health facility and continuum of vaccination behaviors among Nigerian children

  2020cites this paper
• A Research Agenda for Malaria Eradication: Vaccines

  2019cites this paper
• A Research Agenda for Malaria Eradication: Vaccines

  2019cites this paper
• A Research Agenda for Malaria Eradication: Vaccines

  2019cites this paper
• Optimization of frequency and targeting of measles supplemental immunization activities in Nigeria: A cost-effectiveness analysis.

  2019cites this paper
• A Research Agenda for Malaria Eradication: Vaccines

  2019cites this paper
• A Research Agenda for Malaria Eradication: Vaccines

  2019cites this paper
• Assessing measles vaccine failure in Tianjin, China.

  2019cites this paper
• Immunogenicity and Safety of Measles Vaccine in HIV-infected Children: an Updated Systematic Review.

  2019cites this paper
• Protective Immunity against Canine Distemper Virus in Dogs Induced by Intranasal Immunization with a Recombinant Probiotic Expressing the Viral H Protein

  2019cites this paper
• Disease as an evolutionary weapon

  2019cites this paper
• Modified Dose Efficacy Trial of a Canine Distemper-Measles Vaccine for Use in Rhesus Macaques (Macaca mulatta).

  2019cites this paper
• Tropism and molecular pathogenesis of canine distemper virus

  2019cites this paper
• Measles vaccine immune escape: Should we be concerned?

  2019cites this paper
• Maternal antibody transfer in HIV-1 infected women and impact on infant health : the role of antiretroviral prophylaxis and breastfeeding practices

  2019cites this paper
• Measles virus infection diminishes preexisting antibodies that offer protection from other pathogens

  2019cites this paper
• Evaluation of measles immunity in Turkey: is it still a threat?

  2019cites this paper
• Game dynamic model of optimal budget allocation under individual vaccination choice.

  2019cites this paper
• Incomplete genetic reconstitution of B cell pools contributes to prolonged immunosuppression after measles

  2019cites this paper
• A Research Agenda for Malaria Eradication: Vaccines

  2019cites this paper
• Effect of HIV-exposure and timing of anti-retroviral treatment on immunogenicity of trivalent live-attenuated polio vaccine in infants

  2019cites this paper
• Monitoring immune dynamics following infection and vaccination using B cell receptor sequencing

  2018cites this paper
• Revealing Measles Outbreak Risk With a Nested Immunoglobulin G Serosurvey in Madagascar

  2018cites this paper
• Opinion: Making Inactivated and Subunit-Based Vaccines Work

  2018cites this paper
• Measles control in Australia - threats, opportunities and future needs.

  2018cites this paper
• Measles outbreak in a tertiary level hospital, Porto, Portugal, 2018: challenges in the post-elimination era.

  2018cites this paper
• Macrophages and Dendritic Cells Are the Predominant Cells Infected in Measles in Humans

  2018cites this paper
• T Lymphocytes as Measurable Targets of Protection and Vaccination Against Viral Disorders

  2018cites this paper
• Measles Virus Persistent Infection of Human Induced Pluripotent Stem Cells

  2018cites this paper
• Title A Novel Peptide Derived from the Fusion Protein Heptad Repeat Inhibits Replication of Subacute Sclerosing Panencephalitis Virus In Vitro and In Vivo

  2018cites this paper
• Measles vaccine

  2018cites this paper
• Direct and indirect effects of influenza vaccination

  2017cites this paper